MiNK Therapeutics, Inc.
NASDAQ:INKTBiotechnology
Healthcare
$10.22 -2.87%
-$0.35 today
- Market cap
- $52.17M
- Beta
- 0.47
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$2.60
52W Low $6.80High $76.00
Volume 0.01M
Average 0.05M
Balance Sheet
Inspect the capital base behind the business.
Assets
$14.24M
FY 2025 · Annual
+148.9% YoYLiabilities
$28.47M
FY 2025 · Annual
+12.5% YoYEquity
-$14.23M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 38.89M | 19.64M | 3.37M | 4.58M | 13.36M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 23K | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 721.32K | 470.3K | 177.96K | 164.24K | 211.2K |
| Total Current Assets | 39.63M | 20.4M | 3.6M | 4.99M | 13.85M |
| Property, Plant & Equipment (Net) | 606.6K | 1.07M | 953.98K | 732.93K | 390.87K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 606.6K | 1.07M | 953.98K | 732.93K | 390.87K |
| Total Assets | 40.24M | 21.47M | 4.55M | 5.72M | 14.24M |
| Account Payables | 3M | 5.82M | 3.91M | 2.73M | 3.43M |
| Short-term Debt | 0 | 0 | 0 | 0 | 5.18M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.76M | 5.21M | 5.66M | 3.51M | 2.85M |
| Total Current Liabilities | 16.47M | 12.68M | 11.4M | 6.96M | 13.03M |
| Long-term Debt | 0 | 0 | 0 | 4.92M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 9.19M | 11.21M | 13.42M | 15.44M |
| Total Non-current Liabilities | 0 | 9.19M | 11.21M | 18.35M | 15.44M |
| Total Liabilities | 16.47M | 21.87M | 22.61M | 25.31M | 28.47M |
| Common Stock | 335 | 339 | 346 | 40 | 48 |
| Retained Earnings | (82.95M) | (110.94M) | (133.4M) | (144.18M) | (156.68M) |
| Accumulated OCI | (625.27K) | (292.47K) | (430.95K) | (631.58K) | (718.92K) |
| Other Stockholders Equity | 0 | 900 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 23.78M | (401.3K) | (18.06M) | (19.59M) | (14.23M) |
| Total Debt | 0 | 0 | 0 | 4.92M | 5.18M |
| Net Debt | (38.89M) | (19.64M) | (3.37M) | 347.57K | (8.18M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $9.5M |
| Other Current | $496.8K |
| Total Current Assets | $10.0M |
| PP&E (Net) | $354.5K |
| Total Non-current Assets | $354.5K |
| Total Assets | $10.4M |
Analysis
Selected assets total $10.4M for Latest. The largest visible component is Cash & Equivalents at $9.5M, about 91.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Oct 14, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 2, 2026 |
How much cash does INKT have?
MiNK Therapeutics, Inc. (INKT) reported $13.36M in cash and equivalents in fiscal 2025.
How much debt does INKT carry?
MiNK Therapeutics, Inc. (INKT) reported $5.18M of total debt, with net debt of -$8.18M.
Continue the stock analysis
Jump to another research area for this company.